ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
First Drug Coming Soon as Pharmaceutical Companies Take Moves in the B7-H3 Immune Target Products Layout
May 23, 2022Based on public information, TAA06 is an independently developed B7-H3-targeted CAR-T therapy of PersonGen. The drug was granted the Orphan Drug Designation (ODD) for treating neuroblastoma by the FDA (Food and Drug Administration) in March of this year.
Pharma Sources Insight January 2025
